Walaa A. El‐Dakroury
- Cancer Research top 5%
- MicroRNA in disease regulation 21
- Cancer-related molecular mechanisms research 7
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 8
- Advancements in Transdermal Drug Delivery 5
- Drug Solubulity and Delivery Systems 4
- Biomaterials top 10%
- Molecular Medicine top 10%
-
- Circular RNAs in diseases 15
- RNA Interference and Gene Delivery 4
-
- Systemic Lupus Erythematosus Research 4
- Co-authors
- Ahmed S. DoghishMoataz B. ZewailHussein M. El‐HusseinyGihan F. AsaadEman A. MadyAhmed I. AbulsoudSherif S. Abdel MageedNourhan M. Abdelmaksoud
- Journals
- The FASEB Journal (1 paper)Neuroscience & Biobehavioral Reviews (1 paper)Molecules (1 paper)
- Partner nations
- EgyptSaudi ArabiaJapan
In The Last Decade
Walaa A. El‐Dakroury
64 papers receiving 984 citations
Peers
Comparison fields: 5 of 105
- Cancer Research 383
- Pharmaceutical Science 126
- Biomaterials 127
- Molecular Medicine 46
- Molecular Biology 470
Countries citing papers authored by Walaa A. El‐Dakroury
This map shows the geographic impact of Walaa A. El‐Dakroury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walaa A. El‐Dakroury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walaa A. El‐Dakroury more than expected).
Fields of papers citing papers by Walaa A. El‐Dakroury
This network shows the impact of papers produced by Walaa A. El‐Dakroury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walaa A. El‐Dakroury. The network helps show where Walaa A. El‐Dakroury may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Walaa A. El‐Dakroury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 5 | |
| 10 | 2024 | 7 | |
| 11 | 2023 | 25 | |
| 12 | 2023 | 14 | |
| 13 | 2023 | 16 | |
| 14 | 2023 | 40 | |
| 15 | 2023 | 27 | |
| 16 | 2023 | 15 | |
| 17 | 2023 | 55 | |
| 18 | 2023 | 30 | |
| 19 | 2022 | 58 | |
| 20 | 2022 | 37 |
About Walaa A. El‐Dakroury
Walaa A. El‐Dakroury is a scholar working on Pharmaceutical Science, Cancer Research and Biomaterials, having authored 66 papers that have together received 989 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Circular RNAs in diseases (15 papers), Advanced Drug Delivery Systems (8 papers), Cancer-related molecular mechanisms research (7 papers), Advancements in Transdermal Drug Delivery (5 papers), Drug Solubulity and Delivery Systems (4 papers), RNA Interference and Gene Delivery (4 papers) and Systemic Lupus Erythematosus Research (4 papers). The work is most often cited by research in Cancer Research (383 citations), Pharmaceutical Science (126 citations) and Biomaterials (127 citations). Walaa A. El‐Dakroury has collaborated with scholars based in Egypt, Saudi Arabia and Japan. Frequent co-authors include Ahmed S. Doghish, Moataz B. Zewail, Hussein M. El‐Husseiny, Gihan F. Asaad, Eman A. Mady, Ahmed I. Abulsoud, Sherif S. Abdel Mageed, Nourhan M. Abdelmaksoud, Mohammed S. Elballal and Marwa E. Shabana. Their work appears in journals such as The FASEB Journal, Neuroscience & Biobehavioral Reviews and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.